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Abstract - Incidence of chronic heart failure (HF) is 
rapidly increasing, approaching a 10 per 1000 rate after 
65 years of age.  In the last decades,  despite 
pharmacological, interventional and supportive 
innovations, HF prognosis remained poor, with about 
30% of death within one year from the diagnosis. 
Current guidelines recommend for these patients 
management programs providing follow-up through 
dedicated outpatient clinic. Limits of these programs 
are represented by great difficulties in getting patients 
adherence, being still too elevated the rate of 
abandonments. In this paper, we analyzed the impact of 
58 months of activity in our dedicated to heart failure 
outpatient clinic on mortality, hospitalization and 
abandonment rate. 477 HF patients (346 M, 72.5%, 
mean age 69.6 years) were enrolled. Mean follow-up  
and visit were 18.2 and 2.6 months respectively. Total 
mortality rate was 11.5%,  4% of patients per year. 
Total hospitalizations for acute HF were 212 and, 
among all patients left in follow-up, the number of 
hospitalizations for acute de-compensation 
significantly decreased from 0.49/patient/year before 
enrollment to 0.29/patient/year during follow-up 
(p=0.015). Patients who abandoned outpatient clinic 
were 94 (19%, 1 abandonment every 23 days), mostly 
observed over the first months of activity. In 
conclusion, our patients experienced a major decrease 
in rates of acute de-compensation and need of in-
hospital admissions.  
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Incidence of chronic heart failure (HF) still to be 
increased, approaching 10 per 1000 population after 65 
years of age; in white man, the annual rates of new HF 
events are 15.2 every 1000 individuals between 65 to 
85 years, and 65.2 for those ≥85 years of age [1]. In the 
last decades,  despite pharmacological, interventional 
and supportive innovations, HF prognosis remained 
poor, with about 30% of death in one year from the 
diagnosis [2]. Heart failure management summarize 
more than 2% of total healthcare costs, the most of 
which are related to hospitalizations [3]. According to 
current ESC guidelines  [4] HF patients should be 
involved in management programs lead by a 
multidisciplinary team in an outpatient clinic, 
providing for each patient an accurate diagnosis, the 
appropriate evidence-based therapy and education for 
both patients and their carers. This “holistic” approach 
leads  to a significant reduction in hospitalization rate, 
thus improving both survival and quality of life [5-6]. 
Nevertheless these programs are frequently 
insufficient, leading to inadequate support and 
suboptimal treatment. Particularly adherence of 
patients at follow-up is often poor, with still too 
elevated percentage of abandonment. Less is known 
about causes of these poor outcomes, and which 
aspects need more sensitive improvements [7-10]. Aim 
of this paper is to describe our  58 months experience  
in a  dedicated HF outpatient clinic and its impact in 
terms of hospitalizations, abandonments and deaths. A 
service led by a cardiologist and a specialized nurse, in 
which patients can easily get a visit or telephone 






The clinical records of 477 patients admitted to our 
dedicated to heart failure outpatient clinic in the 
University Hospital of Salerno, from January 2009 to 
October 2013, were retrospectively reviewed. Most of 
these patients have been enrolled at time of discharge 
from hospitalization in our institution for HF. All data 
regarding medical history and anthropometric features, 
variation of functional class, in-hospital admissions 
and causes, deaths and abandonments of the follow-up 
were reported.  For any patient medical controls were 
planned at 1 month and at least every 6 months, further 
patients access were performed according to clinical 
judgment. In every visit the anthropometric parameters 
were evaluated and a full cardiological evaluation, 
EKG, pressure measurement, and a critical revision of 
medical therapy were performed; furthermore a 
personalized counseling in order to improve 
pharmacological adherence was performed. A 
transthoracic echocardiography was performed in order 
to evaluate global cardiac function. Any other 
diagnostic exam, as well as specialist medical 
consultancy, were performed according to clinical 
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Continuous variables have been expressed as the mean 
± standard deviation and categorical variables as 
percentage. The analysis of difference between the two 
groups has been performed by student's unpaired t-test 
for continuous variables and χ2 test for categorical 
variables. Wilcoxon signed-rank test was employed to 
compare number of hospitalization/patient/year related 
to heart failure between a period of a year before 
enrollment and during follow-up. The same test was 
used to  compare functional class (NYHA) at time of 
enrollment and during follow-up. All values have been 
analyzed bilaterally and p-values <0.05 have been 
considered significant. All statistical analysis have 
been performed using  SPSS for Windows, version 




Four hundred seventy seven  HF  patients (346 M, 
72.5%, mean age 69.6 years) were enrolled in 58 
months of clinical activity. The predominant HF 
etiology is ischaemic, followed by idiopathic forms, 
hypertensive forms, post valvular disease and post-
myocarditis beeing 53.3, 18.2, 13.9, 8.6 and 1.1% 
respectively. The majority (68%) were NHYA I-II 
class. Mean follow-up was 18.2 months and mean visit 
interval was 2.6 months. Patients which abandoned 
outpatient clinic were 94, 19% of followed patients, 
with an average abandonment every 23 days. Total 
patients deaths were 55: a percentage of 11.5%, 
equivalent to 4% of patients per year, a death every 30 
days, on average (Fig. 1). Total re-hospitalization for 
acute HF were 212. Among all patients left in follow-
up the number of hospitalizations for acute de-
compensation significantly decreased from 
0.49/patient/year before enrollment to 0.29/patient/year 
during follow-up (p=0.015). Total readmission for 
heart failure decreased significantly from 840 to 417 
(p= 0.01) over the follow-up period (Fig. 2). Mortality 
rate decreased from 8.5% in the 2009 to the 3.3 % in 
the 2013 (p = n.s.). Patients followed need an 
hospitalization every 45 months of follow-up, on 
average. Most of patients (167 patients, equivalent to 
52.2% of total, and 78.8% of patients left) in follow-up 
did not need in hospital admissions for heart failure 
during follow-up. Only 45 patients (equivalent to 
21.1% of patients left in follow-up and 14.1% of total 
patients) needed one or more hospitalization for this 
cause. No significant differences in NYHA class 
modification were observed (p =0.839), eventhough an 
interesting trend was pointed out, with a reduction of 
NYHA class III-IV from 42% in 2009 to 27% in the 
last year. Another interesting finding is the constant 
reduction of  hospital admission for diagnosis-related 
groups (DRG) 127 (heart failure). Total hospital 
admission for HF in 2009 represented 6.6% of all 
admission, and after 3 years of ambulatory activity was 
appreciated a reduction till 4.9% of the total amount, 
with a mean absolute reduction of 228 admission/year. 
A linear correlation between total hospital admission 
and DRG 127 (r=99.86)  and DRG 127 and 
hospitalization (r=99.45) were also observed (Fig. 3). 
One, two and three or more comorbidities, were 
respectively observed in 203 patients (64%), 57 
patients (18%) and 10 patients (3.1%). The most 
common comorbidity was diabetes, followed by 
chronic kidney disease and respiratory diseases. Total 
deaths were 55, 11.5% of our population; among them 
45 patients (83%) showed at least one comorbidity, and 
11 (20%), 42 (76.3%) and 2 (3.4%) were in II, III and 




The actually recommended programs for chronic care 
management of heart failure provide, among other 
things, structured follow-up in a dedicated outpatient 
clinic. Our service ensure a dedicated follow-up, with 
patient education, regular control of pharmacological 
treatment, and easy access to care and visit.  But 
management programs, on the other hand, should be 
multidisciplinary with intervention of different 
professional figures, and primarily providing a chain-
of-care delivered by various services of the healthcare 
system [11-19]. Unfortunately we have not been able 
yet to create appropriate links and collaboration with 
primary care providers and other figures. First of all the 
link between the heart team and the general practitioner 
is crucial, thus ensuring the continuity of cares; 
unfortunately it is not always possible. Nevertheless, 
some clinical outcomes were very encouraging: only 
one fifth of patients needed an hospitalization due to 
heart failure during follow-up, whereas less than 1/7 
seven died during  this period. A notable aspect is that 
most patients were enrolled for follow-up at time of 
discharge, and all have been assessed by cardiologists. 
Another possibility of enrollment is by using our 
dedicated internet page, in which the general 
practitioner or colleagues from community hospitals 
could require a specialist visit directly from their 
workplace. Since the availability of internet patient 
even more patients are sent from peripheral centers, 
making our outpatient clinic ever more rooted in the 
territory. Furthermore, percentage of abandonments 
was also quite limited: about 1/5 abandoned the follow-
up. Not equally appreciable was datum related to 
frequency of visits: each patient came for visit every 96 
days, on average. This in spite of our efforts to make 
easy access and telephonic contact with nurse and 
cardiologist. Recently we have postulate the possibility 
of using a new marker for the characterization of heart 
failure and preliminary results are encouraging [20]. 
Percentage of patients lost for follow-up and frequency 
of visit, are two aspects strongly linked to  “chain of 
care” of healthcare. Moreover these aspects could 
probably affect other clinical outcome (especially 
mortality and hospitalization).  NHYA functional class 
was not significantly modified during the follow-up, 
but this aspect was not surprising because patients 
shows a prevalent low NYHA class at enrollment time; 
an indirect evaluation of these finding reveals the 
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prolonged maintenance of low NYHA class and a 
relative good clinical condition. Global NYHA class 
III-IV reduction from 42% in 2009 to 27% of overall 
population in 2013 are mainly related to drugs 
compliance and home monitoring. Finally, analyzing 
global mortality data more than 80% of death were in 
advanced NYHA class and we observed a progressive 
rate reduction from 8.5% in the 2009 to the 4.3% in the 
2013. Our mortality rate is lower than IN-CHF registry, 
in which it was reported as about 10% [21]. It could 
possibly derive from either the enrollment modality, 
with an higher prevalence of lower NYHA class (I-II) 




The results of 58 months of work in our dedicated 
outpatient clinic confirm value of management 
programs for patients with HF, but suggest that still 
efforts are needed to improving adherence at these 
programs. Our patients experienced sensitive decrease 
in frequency of acute de-compensation and need of in-
hospital admissions. Perhaps this phenomenon could 
be mitigated through a more efficient organization of 
our outpatient clinic and/or involvement of other 
territorial institutions, with different professional 
figures, in order to improve satisfaction degree and 
communication tools with our patients. A more 
structured and comprehensive strategy is needed for 
improve loyalty of our patients, and consequently 
clinical outcomes.  The improvement of the internet 
available services could be an effective strategy to 




Figure 1. Percentage mortality reduction from 2009 
to 2013, with a progressive increase of followed 




Figure 2. Comparison between overall hospital 
admission and admission for diagnosis-related 




Figure 3. Linear correlation between total hospital 
admission and diagnosis-related groups (DRG) 127 
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